This week, the P4A team analyse the new regulations surrounding health technology assessments in Europe and US-based CAR-T start-up Allogene Therapeutic's record-breaking initial public offering.
Presenter: Max Rex
Contributor: Christina Poschen, Consultant, P4A
view more